Biomarin Pharmaceutical (BMRN) Land & Improvements (2010 - 2013)

Biomarin Pharmaceutical's Land & Improvements history runs 4 years deep, the most recent figure standing at $74.9 million for Q4 2013.

• Quarterly Land & Improvements rose 33.81% year-over-year to $74.9 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $74.9 million (up 33.81% YoY) and the FY2013 annual result came in at $74.9 million, up 33.81% from the prior year.
• Land & Improvements was $74.9 million for Q4 2013 at Biomarin Pharmaceutical, up from $63.2 million in the prior quarter.
• Across five years, Land & Improvements topped out at $74.9 million in Q4 2013 and bottomed at $10.1 million in Q2 2012.
• A 4-year average of $51.0 million and a median of $54.5 million in 2012 frame the typical range for Land & Improvements.
• Annual changes were most pronounced in 2012 — Land & Improvements advanced 15.33% — and 2013, when it surged 501.02%.
• Biomarin Pharmaceutical's Land & Improvements stood at $37.7 million in 2010, then rose by 28.99% to $48.6 million in 2011, then gained by 15.33% to $56.0 million in 2012, then surged by 33.81% to $74.9 million in 2013.
• Business Quant data shows BMRN's Land & Improvements at $74.9 million in Q4 2013, $63.2 million in Q3 2013, and $60.4 million in Q2 2013.